Reciprocal regulation of cholesterol and beta amyloid at the subcellular level in alzheimer's disease

Canadian Journal of Physiology and Pharmacology

Volumn 90, Issue 6, 2012, Pages 753-764

  Posse de Chaves, Elena ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

A Peptide; Alzheimer; Cholesterol; Protein neurodegeneration; Trafficking

Indexed keywords

AMYLOID BETA PROTEIN; CHOLESTEROL;

ALZHEIMER DISEASE; CELL LEVEL; CELL MEMBRANE; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; HUMAN; NERVE DEGENERATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; APOLIPOPROTEINS E; CHOLESTEROL; HUMANS;

EID: 84870653585     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y2012-076     Document Type: Review

References (154)

1. Abad-Rodriguez, J., Ledesma, M.D., Craessaerts, K., Perga, S., Medina, M., Delacourte, A., et al. 2004. Neuronal membrane cholesterol loss enhances amyloid peptide generation. J. Cell Biol. 167(5): 953-960. doi:10.1083/jcb.200404149. PMID:15583033.
2. Abramov, A.Y., Ionov, M., Pavlov, E., and Duchen, M.R. 2011. Membrane cholesterol content plays a key role in the neurotoxicity of beta-amyloid: implications for Alzheimer's disease. Aging Cell, 10(4): 595-603. doi:10.1111/j.1474-9726.2011.00685.x. PMID: 21332922.
3. Aho, L., Pikkarainen, M., Hiltunen, M., Leinonen, V., and Alafuzoff, I. 2010. Immunohistochemical visualization of amyloid-beta protein precursor and amyloid-beta in extra- and intracellular compartments in the human brain. J. Alzheimers Dis. 20(4): 1015-1028. PMID:20413866.
4. Almeida, C.G., Tampellini, D., Takahashi, R.H., Greengard, P., Lin, M.T., Snyder, E.M., and Gouras, G.K. 2005. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol. Dis. 20(2): 187-198. doi:10. 1016/j.nbd.2005.02.008. PMID:16242627.
5. Almeida, C.G., Takahashi, R.H., and Gouras, G.K. 2006. Betaamyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system. J. Neurosci. 26(16): 4277-4288. doi:10.1523/JNEUROSCI.5078-05.2006. PMID: 16624948.
6. Aqul, A., Liu, B., Ramirez, C.M., Pieper, A.A., Estill, S.J., Burns, D.K., et al. 2011. Unesterified cholesterol accumulation in late endosomes/lysosomes causes neurodegeneration and is prevented by driving cholesterol export from this compartment. J. Neurosci. 31(25): 9404-9413. doi:10.1523/JNEUROSCI.1317- 11.2011. PMID:21697390.
7. Arispe, N., and Doh, M. 2002. Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AbP (1-40) and (1-42) peptides. FASEB J. 16(12): 1526-1536. doi:10.1096/fj.02- 0829com. PMID:12374775.
8. Ashley, R.H., Harroun, T.A., Hauss, T., Breen, K.C., and Bradshaw, J.P. 2006. Autoinsertion of soluble oligomers of Alzheimer's Ab(1-42) peptide into cholesterol-containing membranes is accompanied by relocation of the sterol towards the bilayer surface. BMC Struct. Biol. 6(1): 21-32. doi:10.1186/1472-6807-6- 21. PMID:17052343.
9. Avdulov, N.A., Chochina, S.V., Igbavboa, U., Warden, C.S., Vassiliev, A.V., and Wood, W.G. 1997. Lipid binding to amyloid beta-peptide aggregates: preferential binding of cholesterol as compared with phosphatidylcholine and fatty acids. J. Neurochem. 69(4): 1746-1752. doi:10.1046/j.1471-4159.1997.69041746.x. PMID:9326304.
10. Bahr, B.A., Hoffman, K.B., Yang, A.J., Hess, U.S., Glabe, C.G., and Lynch, G. 1998. Amyloid beta protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor protein. J. Comp. Neurol. 397(1): 139-147. doi:10.1002/ (SICI)1096-9861(19980720)397:1<139::AID-CNE10>3.0.CO;2- K. PMID:9671284.
11. Beel, A.J., Sakakura, M., Barrett, P.J., and Sanders, C.R. 2010. Direct binding of cholesterol to the amyloid precursor protein: An important interaction in lipid-Alzheimer's disease relationships? Biochim. Biophys. Acta, 1801(8): 975-982. PMID:20304095.
12. Bi, X., Gall, C.M., Zhou, J., and Lynch, G. 2002. Uptake and pathogenic effects of amyloid beta peptide 1-42 are enhanced by integrin antagonists and blocked by NMDA receptor antagonists. Neuroscience, 112(4): 827-840. doi:10.1016/S0306-4522(02) 00132-X. PMID:12088742.
13. Billings, L.M., Oddo, S., Green, K.N., McGaugh, J.L., and LaFerla, F.M. 2005. Intraneuronal Ab causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron, 45 (5): 675-688. doi:10.1016/j.neuron.2005.01.040. PMID: 15748844.
14. Burdick, D., Kosmoski, J., Knauer, M.F., and Glabe, C.G. 1997. Preferential adsorption, internalization and resistance to degradation of the major isoform of the Alzheimer's amyloid peptide, A beta 1-42, in differentiated PC12 cells. Brain Res. 746(1-2): 275-284. doi:10.1016/S0006-8993(96)01262-0. PMID:9037507.
15. Burns, M.P., and Rebeck, G.W. 2010. Intracellular cholesterol homeostasis and amyloid precursor protein processing. Biochim. Biophys. Acta, 1801(8): 853-859. PMID:20304094.
16. Burns, M., Gaynor, K., Olm, V., Mercken, M., LaFrancois, J., Wang, L., et al. 2003. Presenilin redistribution associated with aberrant cholesterol transport enhances beta-amyloid production in vivo. J. Neurosci. 23(13): 5645-5649. PMID:12843267.
17. Busciglio, J., Pelsman, A., Wong, C., Pigino, G., Yuan, M., Mori, H., and Yankner, B.A. 2002. Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome. Neuron, 33(5): 677-688. doi:10.1016/S0896- 6273(02)00604-9. PMID:11879646.
18. Casas, C., Sergeant, N., Itier, J.M., Blanchard, V., Wirths, O., van der Kolk, N., et al. 2004. Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Ab42 accumulation in a novel Alzheimer transgenic model. Am. J. Pathol. 165(4): 1289-1300. doi:10.1016/S0002-9440(10)63388-3. PMID:15466394.
19. Cataldo, A. M., Barnett, J. L., Pieroni, C., and Nixon, R.A. 1997. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis. J. Neurosci. 17(16): 6142-6151. PMID:9236226.
20. Cecchi, C., Rosati, F., Pensalfini, A., Formigli, L., Nosi, D., Liguri, G., et al. 2008. Seladin-1/DHCR24 protects neuroblastoma cells against Ab toxicity by increasing membrane cholesterol content. J. Cell. Mol. Med. 12(5B): 1990-2002. doi:10.1111/j.1582-4934. 2008.00216.x. PMID:18194465.
21. Cecchi, C., Nichino, D., Zampagni, M., Bernacchioni, C., Evangelisti, E., Pensalfini, A., et al. 2009. A protective role for lipid raft cholesterol against amyloid-induced membrane damage in human neuroblastoma cells. Biochim. Biophys. Acta, 1788(10): 2204-2216. doi:10.1016/j.bbamem.2009.07.019. PMID:19651105.
22. Chartier-Harlin, M.-C., Parfitt, M., Legrain, S., Pérez-Tur, J., Brousseau, T., Evans, A., et al. 1994. Apolipoprotein E, 3 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum. Mol. Genet. 3(4): 569-574. doi:10.1093/hmg/3.4.569. PMID:8069300.
23. Chochina, S.V., Avdulov, N.A., Igbavboa, U., Cleary, J.P., O'Hare, E.O., and Wood, W.G. 2001. Amyloid beta-peptide1-40 increases neuronal membrane fluidity: role of cholesterol and brain region. J. Lipid Res. 42(8): 1292-1297. PMID:11483631.
24. Chui, D.H., Dobo, E., Makifuchi, T., Akiyama, H., Kawakatsu, S., Petit, A., et al. 2001. Apoptotic neurons in Alzheimer's disease frequently show intracellular Ab42 labeling. J. Alzheimers Dis. 3 (2): 231-239. PMID:12214064.
25. Cirrito, J.R., Kang, J.E., Lee, J., Stewart, F.R., Verges, D.K., Silverio, L.M., et al. 2008. Endocytosis is required for synaptic activitydependent release of amyloid-beta in vivo. Neuron, 58(1): 42-51. doi:10.1016/j.neuron.2008.02.003. PMID:18400162.
26. Clifford, P.M., Zarrabi, S., Siu, G., Kinsler, K.J., Kosciuk, M.C., Venkataraman, V., et al. 2007. Ab peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons. Brain Res. 1142: 223-236. doi:10.1016/j.brainres.2007. 01.070. PMID:17306234.
27. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., et al. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261(5123): 921-923. doi:10.1126/ science.8346443. PMID:8346443.
28. Cossec, J.C., Marquer, C., Panchal, M., Lazar, A.N., Duyckaerts, C., and Potier, M.C. 2010. Cholesterol changes in Alzheimer's disease: methods of analysis and impact on the formation of enlarged endosomes. Biochim. Biophys. Acta, 1801(8): 839-845. PMID:20348021.
29. Cossec, J.C., Simon, A., Marquer, C., Moldrich, R.X., Leterrier, C., Rossier, J., et al. 2010. Clathrin-dependent APP endocytosis and Ab secretion are highly sensitive to the level of plasma membrane cholesterol. Biochim. Biophys. Acta, 1801(8): 846-852. PMID: 20580937.
30. Cuello, A.C. 2005. Intracellular and extracellular Ab, a tale of two neuropathologies. Brain Pathol. 15(1): 66-71. doi:10.1111/j.1750- 3639.2005.tb00101.x. PMID:15779238.
31. Cutler, R.G., Kelly, J., Storie, K., Pedersen, W.A., Tammara, A., Hatanpaa, K., et al. 2004. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 101 (7): 2070-2075. doi:10.1073/pnas.0305799101. PMID:14970312.
32. D'Andrea, M.R., Nagele, R.G., Wang, H.Y., Peterson, P.A., and Lee, D.H. 2001. Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology, 38(2): 120-134. doi:10.1046/j.1365-2559.2001. 01082.x. PMID:11207825.
33. de Chaves, E.I., Rusinol, A.E., Vance, D.E., Campenot, R.B., and Vance, J.E. 1997. Role of lipoproteins in the delivery of lipids to axons during axonal regeneration. J. Biol. Chem. 272(49): 30766-30773. doi:10.1074/jbc.272.49.30766. PMID:9388216.
34. Di Paolo, G., and Kim, T.W. 2011. Linking lipids to Alzheimer's disease: cholesterol and beyond. Nat. Rev. Neurosci. 12(5): 284-296. doi:10.1038/nrn3012. PMID:21448224.
35. Dietschy, J.M., and Turley, S.D. 2004. Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J. Lipid Res. 45(8): 1375-1397. doi:10.1194/jlr.R400004-JLR200. PMID: 15254070.
36. Distl, R., Treiber-Held, S., Albert, F., Meske, V., Harzer, K., and Ohm, T.G. 2003. Cholesterol storage and tau pathology in Niemann-Pick type C disease in the brain. J. Pathol. 200(1): 104-111. doi:10.1002/path.1320. PMID:12692848.
37. Ditaranto, K., Tekirian, T.L., and Yang, A.J. 2001. Lysosomal membrane damage in soluble Ab-mediated cell death in Alzheimer's disease. Neurobiol. Dis. 8(1): 19-31. doi:10.1006/ nbdi.2000.0364. PMID:11162237.
38. Ehehalt, R., Keller, P., Haass, C., Thiele, C., and Simons, K. 2003. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J. Cell Biol. 160(1): 113-123. doi:10.1083/jcb.200207113. PMID:12515826.
39. Fassbender, K., Simons, M., Bergmann, C., Stroick, M., Lütjohann, D., Keller, P., et al. 2001. Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Ab 42 and Ab 40 in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 98(10): 5856-5861. doi:10.1073/pnas.081620098. PMID:11296263.
40. Fernández, A., Llacuna, L., Fernández-Checa, J.C., and Colell, A. 2009. Mitochondrial cholesterol loading exacerbates amyloid beta peptide-induced inflammation and neurotoxicity. J. Neurosci. 29 (20): 6394-6405. doi:10.1523/JNEUROSCI.4909-08.2009. PMID:19458211.
41. Friedrich, R.P., Tepper, K., Ronicke, R., Soom, M., Westermann, M., Reymann, K., et al. 2010. Mechanism of amyloid plaque formation suggests an intracellular basis of Ab pathogenicity. Proc. Natl. Acad. Sci. U.S.A. 107(5): 1942-1947. doi:10.1073/pnas. 0904532106. PMID:20133839.
42. Fünfschilling, U., Saher, G., Xiao, L., Möbius, W., and Nave, K.A. 2007. Survival of adult neurons lacking cholesterol synthesis in vivo. BMC Neurosci. 8(1): 1-9. doi:10.1186/1471-2202-8-1. PMID:17199885.
43. Gibson Wood, W., Eckert, G.P., Igbavboa, U., and Müller, W.E. 2003. Amyloid beta-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer's disease. Biochim. Biophys. Acta, 1610(2): 281-290. doi:10.1016/S0005-2736(03) 00025-7. PMID:12648781.
44. Glabe, C. 2001. Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease. J. Mol. Neurosci. 17(2): 137-145. doi:10.1385/JMN:17:2:137. PMID:11816787.
45. Gómez-Ramos, P., and Asuncion Moran, M. 2007. Ultrastructural localization of intraneuronal Ab-peptide in Alzheimer disease brains. J. Alzheimers Dis. 11(1): 53-59. PMID:17361035.
46. Gong, J.S., Sawamura, N., Zou, K., Sakai, J., Yanagisawa, K., and Michikawa, M. 2002. Amyloid beta-protein affects cholesterol metabolism in cultured neurons: implications for pivotal role of cholesterol in the amyloid cascade. J. Neurosci. Res. 70(3): 438-446. doi:10.1002/jnr.10347. PMID:12391604.
47. Gouras, G.K., Tsai, J., Naslund, J., Vincent, B., Edgar, M., Checler, F., et al. 2000. Intraneuronal Ab42 accumulation in human brain. Am. J. Pathol. 156(1): 15-20. doi:10.1016/S0002-9440(10)64700- 1. PMID:10623648.
48. Goritz, C., Mauch, D.H., and Pfrieger, F.W. 2005. Multiple mechanisms mediate cholesterol-induced synaptogenesis in a CNS neuron. Mol. Cell. Neurosci. 29(2): 190-201. PMID: 15911344.
49. Gouras, G.K., Almeida, C.G., and Takahashi, R.H. 2005. Intraneuronal Ab accumulation and origin of plaques in Alzheimer's disease. Neurobiol. Aging, 26(9): 1235-1244. doi:10.1016/j. neurobiolaging.2005.05.022. PMID:16023263.
50. Greeve, I., Hermans-Borgmeyer, I., Brellinger, C., Kasper, D., Gomez-Isla, T., Behl, C., et al. 2000. The human DIMINUTO/ DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. J. Neurosci. 20(19): 7345-7352. PMID:11007892.
51. Grimm, M.O., Grimm, H.S., Patzold, A.J., Zinser, E.G., Halonen, R., Duering, M., et al. 2005. Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin. Nat. Cell Biol. 7(11): 1118-1123. doi:10.1038/ncb1313. PMID: 16227967.
52. Haass, C., Schlossmacher, M.G., Hung, A.Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B.L., et al. 1992. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature, 359(6393): 322-325. doi:10.1038/359322a0. PMID:1383826.
53. Hardy, J., and Allsop, D. 1991. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci. 12(10): 383-388. doi:10.1016/0165-6147(91)90609-V. PMID:1763432.
54. Hardy, J.A., and Higgins, G.A. 1992. Alzheimer's disease: the amyloid cascade hypothesis. Science, 256(5054): 184-185. doi:10. 1126/science.1566067. PMID:1566067.
55. Hayashi, H., Igbavboa, U., Hamanaka, H., Kobayashi, M., Fujita, S.C., Gibson Wood, W., and Yanagisawa, K. 2002. Cholesterol is increased in the exofacial leaflet of synaptic plasma membranes of human apolipoprotein E4 knock-in mice. Neuroreport, 13(4): 383-386. doi:10.1097/00001756-200203250-00004. PMID: 11930145.
56. Hölttä-Vuori, M., Tanhuanpää, K., Möbius, W., Somerharju, P., and Ikonen, E. 2002. Modulation of cellular cholesterol transport and homeostasis by Rab11. Mol. Biol. Cell, 13(9): 3107-3122. doi:10. 1091/mbc.E02-01-0025. PMID:12221119.
57. Hu, X., Crick, S.L., Bu, G., Frieden, C., Pappu, R.V., and Lee, J.M. 2009. Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide. Proc. Natl. Acad. Sci. U.S.A. 106(48): 20324-20329. doi:10.1073/pnas.0911281106. PMID:19910533.
58. Igbavboa, U., Avdulov, N.A., Schroeder, F., and Wood, W.G. 1996. Increasing age alters transbilayer fluidity and cholesterol asymmetry in synaptic plasma membranes of mice. J. Neurochem. 66 (4): 1717-1725. doi:10.1046/j.1471-4159.1996.66041717.x. PMID:8627330.
59. Igbavboa, U., Pidcock, J.M., Johnson, L.N., Malo, T.M., Studniski, A.E., Yu, S., et al. 2003. Cholesterol distribution in the Golgi complex of DITNC1 astrocytes is differentially altered by fresh and aged amyloid beta-peptide-(1-42). J. Biol. Chem. 278(19): 17150-17157. doi:10.1074/jbc.M301150200. PMID:12584199.
60. Igbavboa, U., Sun, G.Y., Weisman, G.A., He, Y., and Wood, W.G. 2009. Amyloid beta-protein stimulates trafficking of cholesterol and caveolin-1 from the plasma membrane to the Golgi complex in mouse primary astrocytes. Neuroscience, 162(2): 328-338. doi:10. 1016/j.neuroscience.2009.04.049. PMID:19401218.
61. Jin, L.-W., Shie, F.S., Maezawa, I., Vincent, I., and Bird, T. 2004. Intracellular accumulation of amyloidogenic fragments of amyloid- beta precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities. Am. J. Pathol. 164(3): 975-985. doi:10.1016/S0002-9440(10)63185-9. PMID: 14982851.
62. Kaether, C., and Haass, C. 2004. A lipid boundary separates APP and secretases and limits amyloid beta-peptide generation. J. Cell Biol. 167(5): 809-812. doi:10.1083/jcb.200410090. PMID:15583026.
63. Kakio, A., Nishimoto, S.I., Yanagisawa, K., Kozutsumi, Y., and Matsuzaki, K. 2001. Cholesterol-dependent formation of GM1 ganglioside-bound amyloid beta-protein, an endogenous seed for Alzheimer amyloid. J. Biol. Chem. 276(27): 24985-24990. doi:10. 1074/jbc.M100252200. PMID:11342534.
64. Kalvodova, L., Kahya, N., Schwille, P., Ehehalt, R., Verkade, P., Drechsel, D., and Simons, K. 2005. Lipids as modulators of proteolytic activity of BACE: involvement of cholesterol, glycosphingolipids, and anionic phospholipids in vitro. J. Biol. Chem. 280(44): 36815-36823. doi:10.1074/jbc.M504484200. PMID: 16115865.
65. Kawarabayashi, T., Younkin, L.H., Saido, T.C., Shoji, M., Ashe, K.H., and Younkin, S.G. 2001. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J. Neurosci. 21(2): 372-381. PMID:11160418.
66. Knauer, M.F., Soreghan, B., Burdick, D., Kosmoski, J., and Glabe, C.G. 1992. Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein. Proc. Natl. Acad. Sci. U.S.A. 89(16): 7437-7441. doi:10.1073/pnas.89.16.7437. PMID: 1502155.
67. Koh, C.H., and Cheung, N.S. 2006. Cellular mechanism of U18666A-mediated apoptosis in cultured murine cortical neurons: bridging Niemann-Pick disease type C and Alzheimer's disease. Cell. Signal. 18(11): 1844-1853. doi:10.1016/j.cellsig.2006.04. 006. PMID:16797161.
68. Kojro, E., Gimpl, G., Lammich, S., Marz, W., and Fahrenholz, F. 2001. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the a-secretase ADAM 10. Proc. Natl. Acad. Sci. U.S.A. 98(10): 5815-5820. doi:10.1073/pnas.081612998. PMID: 11309494.
69. Kokubo, H., Kayed, R., and Yamaguchi, H. 2005. Soluble Ab oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain. Brain Res.1031(2): 222-228. PMID:15649447.
70. Koo, E.H., and Squazzo, S.L. 1994. Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J. Biol. Chem. 269(26): 17386-17389. PMID:8021238.
71. Kosicek, M., Malnar, M., Goate, A., and Hecimovic, S. 2010. Cholesterol accumulation in Niemann Pick type C (NPC) model cells causes a shift in APP localization to lipid rafts. Biochem. Biophys. Res. Commun. 393(3): 404-409. doi:10.1016/j.bbrc. 2010.02.007. PMID:20138836.
72. Koudinova, N.V., Berezov, T.T., and Koudinov, A.R. 1996. Multiple inhibitory effects of Alzheimer's peptide Ab1-40 on lipid biosynthesis in cultured human HepG2 cells. FEBS Lett. 395(2- 3): 204-206. doi:10.1016/0014-5793(96)01042-3. PMID: 8898096.
73. LaFerla, F.M., Tinkle, B.T., Bieberich, C.J., Haudenschild, C.C., and Jay, G. 1995. The Alzheimer's Ab peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat. Genet. 9(1): 21-30. doi:10.1038/ng0195-21. PMID:7704018.
74. LaFerla, F.M., Troncoso, J.C., Strickland, D.K., Kawas, C.H., and Jay, G. 1997. Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Ab stabilization. J. Clin. Invest. 100(2): 310-320. doi:10.1172/JCI119536. PMID:9218507.
75. Langui, D., Girardot, N., El Hachimi, K.H., Allinquant, B., Blanchard, V., Pradier, L., and Duyckaerts, C. 2004. Subcellular topography of neuronal Ab peptide in APPxPS1 transgenic mice. Am. J. Pathol. 165(5): 1465-1477. doi:10.1016/S0002-9440(10) 63405-0. PMID:15509518.
76. Liu, Y., Peterson, D.A., and Schubert, D. 1998. Amyloid beta peptide alters intracellular vesicle trafficking and cholesterol homeostasis. Proc. Natl. Acad. Sci. U.S.A. 95(22): 13266-13271. doi:10.1073/ pnas.95.22.13266. PMID:9789077.
77. Liu, J.P., Tang, Y., Zhou, S., Toh, B.H., McLean, C., and Li, H. 2010. Cholesterol involvement in the pathogenesis of neurodegenerative diseases. Mol. Cell. Neurosci. 43(1): 33-42. doi:10.1016/j.mcn. 2009.07.013. PMID:19660552.
78. Luciani, P., Deledda, C., Rosati, F., Benvenuti, S., Cellai, I., Dichiara, F., et al. 2008. Seladin-1 is a fundamental mediator of the neuroprotective effects of estrogen in human neuroblast long-term cell cultures. Endocrinology, 149(9): 4256-4266. doi:10.1210/en. 2007-1795. PMID:18499757.
79. Lütjohann, D. 2006. Cholesterol metabolism in the brain: importance of 24S-hydroxylation. Acta Neurol. Scand. Suppl. 114(s185): 33-42. doi:10.1111/j.1600-0404.2006.00683.x. PMID:16866909.
80. Malnar, M., Kosicek, M., Mitterreiter, S., Omerbasic, D., Lichtenthaler, S.F., Goate, A., and Hecimovic, S. 2010. Niemann-Pick type C cells show cholesterol dependent decrease of APP expression at the cell surface and its increased processing through the bsecretase pathway. Biochim. Biophys. Acta, 1802(7-8): 682-691. PMID:20493254.
81. Marquer, C., Devauges, V., Cossec, J.C., Liot, G., Lecart, S., Saudou, F., et al. 2011. Local cholesterol increase triggers amyloid precursor protein-Bace1 clustering in lipid rafts and rapid endocytosis. FASEB J. 25(4): 1295-1305. doi:10.1096/fj.10- 168633. PMID:21257714.
82. Martin, M., Dotti, C.G., and Ledesma, M.D. 2010. Brain cholesterol in normal and pathological aging. Biochim. Biophys. Acta, 1801 (8): 934-944. PMID:20359547.
83. Martins, I.J., Berger, T., Sharman, M.J., Verdile, G., Fuller, S.J., and Martins, R.N. 2009. Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease. J. Neurochem. 111(6): 1275-1308. doi:10.1111/j.1471-4159.2009.06408.x. PMID:20050287.
84. Matsuzaki, K., Kato, K., and Yanagisawa, K. 2010. Ab polymerization through interaction with membrane gangliosides. Biochim. Biophys. Acta, 1801(8): 868-877. PMID:20117237.
85. Mattsson, N., Zetterberg, H., Bianconi, S., Yanjanin, N.M., Fu, R., Mansson, J.E., et al. 2011. Gamma-secretase-dependent amyloid-b is increased inNiemann-Pick type C: a cross-sectional study. Neurology, 76(4): 366-372. doi:10.1212/WNL.0b013e318208f4ab. PMID: 21205675.
86. Maxfield, F.R., and van Meer, G. 2010. Cholesterol, the central lipid of mammalian cells. Curr. Opin. Cell Biol. 22(4): 422-429. PMID: 20627678.
87. Meyer-Luehmann, M., Spires-Jones, T.L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., et al. 2008. Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature, 451(7179): 720-724. doi:10.1038/ nature06616. PMID:18256671.
88. Minati, L., Edginton, T., Grazia Bruzzone, M., and Giaccone, G. 2009. Current concepts in Alzheimer's disease: a multidisciplinary review. Am. J. Alzheimers Dis. Other Demen. 24(2): 95-121. doi:10.1177/1533317508328602. PMID:19116299.
89. Mohamed, A., and Posse de Chaves, E. 2011. Ab internalization by neurons and glia. Int. J. Alzheimers Dis. 2011: 127984. PMID: 21350608.
90. Mohamed, A., Cortez, L., and Posse de Chaves, E. 2011. Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Curr. Protein Pept. Sci. 12(3): 235-257. doi:10.2174/ 138920311795860214. PMID:21348837.
91. Mohammed, A., Saavedra, L., DiPardo, A., Sippione, S., and Posse de Chaves, E. 2012. Ab inhibits protein prenylation and induces cholesterol sequestration by impairing SREBP-2 clevage. J. Neurosci., In press.
92. Mori, T., Paris, D., Town, T., Rojiani, A.M., Sparks, D.L., Delledonne, A., et al. 2001. Cholesterol accumulates in senile plaques of Alzheimer disease patients and in transgenic APP(SW) mice. J. Neuropathol. Exp. Neurol. 60(8): 778-785. PMID: 11487052.
93. Muresan, V., and Muresan, Z. 2009. Is abnormal axonal transport a cause, a contributing factor or a consequence of the neuronal pathology in Alzheimer's disease?. Future Neurol. 4(6): 761-773. PMID:20076770.
94. Nagele, R.G., D'Andrea, M.R., Anderson, W.J., and Wang, H.Y. 2002. Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience, 110(2): 199-211. doi:10.1016/ S0306-4522(01)00460-2. PMID:11958863.
95. Nicholson, A.M., and Ferreira, A. 2009. Increased membrane cholesterol might render mature hippocampal neurons more susceptible to beta-amyloid-induced calpain activation and tau toxicity. J. Neurosci. 29(14): 4640-4651. doi:10.1523/ JNEUROSCI.0862-09.2009. PMID:19357288.
96. Nieweg, K., Schaller, H., and Pfrieger, F.W. 2009. Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats. J. Neurochem. 109(1): 125-134. doi:10. 1111/j.1471-4159.2009.05917.x. PMID:19166509.
97. Nixon, R.A. 2004. Niemann-Pick Type C disease and Alzheimer's disease: the APP-endosome connection fattens up. Am. J. Pathol. 164(3): 757-761. doi:10.1016/S0002-9440(10)63163-X. PMID: 14982829.
98. Nixon, R.A. 2005. Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases. Neurobiol. Aging, 26(3): 373-382. PMID:15639316.
99. Oddo, S., Caccamo, A., Shepherd, J.D., Murphy, M.P., Golde, T.E., Kayed, R., et al. 2003. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Ab and synaptic dysfunction. Neuron, 39(3): 409-421. doi:10.1016/S0896-6273 (03)00434-3. PMID:12895417.
100. Ohm, T.G., Treiber-Held, S., Distl, R., Glockner, F., Schonheit, B., Tamanai, M., and Meske, V. 2003. Cholesterol and tau protein- findings in Alzheimer's and Niemann Pick C's disease. Pharmacopsychiatry, 36(Suppl. 2): S120-S126. doi:10.1055/s-2003- 43060. PMID:14574625.
101. Ohyagi, Y., Tsuruta, Y., Motomura, K., Miyoshi, K., Kikuchi, H., Iwaki, T., et al. 2007. Intraneuronal amyloid beta42 enhanced by heating but counteracted by formic acid. J. Neurosci. Methods, 159 (1): 134-138. doi:10.1016/j.jneumeth.2006.06.010. PMID: 16860394.
102. Osenkowski, P., Ye, W., Wang, R., Wolfe, M.S., and Selkoe, D.J. 2008. Direct and potent regulation of gamma-secretase by its lipid microenvironment. J. Biol. Chem. 283(33): 22529-22540. doi:10. 1074/jbc.M801925200. PMID:18539594.
103. Pensalfini, A., Zampagni, M., Liguri, G., Becatti, M., Evangelisti, E., Fiorillo, C., et al. 2011. Membrane cholesterol enrichment prevents Ab-induced oxidative stress in Alzheimer's fibroblasts. Neurobiol. Aging, 32(2): 210-222. doi:10.1016/j.neurobiolaging. 2009.02.010. PMID:19297055.
104. Peri, A., and Serio, M. 2008. Neuroprotective effects of the Alzheimer's disease-related gene seladin-1. J. Mol. Endocrinol. 41(5): 251-261. doi:10.1677/JME-08-0071. PMID:18768664.
105. Peri, A., Benvenuti, S., Luciani, P., Deledda, C., and Cellai, I. 2011. Membrane cholesterol as a mediator of the neuroprotective effects of estrogens. Neuroscience, 191: 107-117. doi:10.1016/j. neuroscience.2011.03.011. PMID:21396986.
106. Pfrieger, F.W. 2003. Cholesterol homeostasis and function in neurons of the central nervous system. Cell. Mol. Life Sci. 60(6): 1158-1171. PMID:12861382.
107. Pfrieger, F.W., and Ungerer, N. 2011. Cholesterol metabolism in neurons and astrocytes. Prog. Lipid Res. 50(4): 357-371. doi:10. 1016/j.plipres.2011.06.002. PMID:21741992.
108. Poirier, J., Bertrand, P., Poirier, J., Kogan, S., Gauthier, S., Poirier, J., et al. 1993. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet, 342(8873): 697-699. doi:10.1016/0140-6736(93) 91705-Q. PMID:8103819.
109. Posse de Chaves, E., and Narayanaswami, V. 2008. Apolipoprotein E and cholesterol in aging and disease in the brain. Future Lipidol. 3 (5): 505-530. doi:10.2217/17460875.3.5.505. PMID:19649144.
110. Posse de Chaves, E.I., Vance, D.E., Campenot, R.B., Kiss, R.S., and Vance, J.E. 2000. Uptake of lipoproteins for axonal growth of sympathetic neurons. J. Biol. Chem. 275(26): 19883-19890. doi:10.1074/jbc.275.26.19883. PMID:10867025.
111. Rajendran, L., Honsho, M., Zahn, T.R., Keller, P., Geiger, K.D., Verkade, P., and Simons, K. 2006. Alzheimer's disease betaamyloid peptides are released in association with exosomes. Proc. Natl. Acad. Sci. U.S.A. 103(30): 11172-11177. doi:10.1073/pnas. 0603838103. PMID:16837572.
112. Riddell, D.R., Christie, G., Hussain, I., and Dingwall, C. 2001. Compartmentalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts. Curr. Biol. 11(16): 1288-1293. doi:10.1016/S0960-9822(01)00394-3. PMID:11525745.
113. Runz, H., Rietdorf, J., Tomic, I., de Bernard, M., Beyreuther, K., Pepperkok, R., and Hartmann, T. 2002. Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells. J. Neurosci. 22(5): 1679-1689. PMID:11880497.
114. Rushworth, J.V., and Hooper, N.M. 2010. Lipid rafts: linking Alzheimer's amyloid-beta production, aggregation, and toxicity at neuronal membranes. Int. J. Alzheimers Dis. 2011: 603052. PMID:21234417.
115. Saavedra, L., Mohamed, A., Ma, V., Kar, S., and de Chaves, E.P. 2007. Internalization of beta-amyloid peptide by primary neurons in the absence of apolipoprotein E. J. Biol. Chem. 282(49): 35722-35732. doi:10.1074/jbc.M701823200. PMID:17911110.
116. Saher, G., Brugger, B., Lappe-Siefke, C., Mobius, W., Tozawa, R., Wehr, M.C., et al. 2005. High cholesterol level is essential for myelin membrane growth. Nat. Neurosci. 8(4): 468-475. PMID:15793579.
117. Saito, Y., Suzuki, K., Nanba, E., Yamamoto, T., Ohno, K., and Murayama, S. 2002. Niemann-Pick type C disease: accelerated neurofibrillary tangle formation and amyloid beta deposition associated with apolipoprotein E epsilon 4 homozygosity. Ann. Neurol. 52(3): 351-355. doi:10.1002/ana.10266. PMID: 12205649.
118. Schmitz, C., Rutten, B.P., Pielen, A., Schafer, S., Wirths, O., Tremp, G., et al. 2004. Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease. Am. J. Pathol. 164(4): 1495-1502. doi:10.1016/S0002-9440(10)63235- X. PMID:15039236.
119. Schreurs, B.G. 2010. The effects of cholesterol on learning and memory. Neurosci. Biobehav. Rev. 34(8): 1366-1379. doi:10. 1016/j.neubiorev.2010.04.010. PMID:20470821.
120. Selkoe, D.J. 1991. The molecular pathology of Alzheimer's disease. Neuron, 6(4): 487-498. doi:10.1016/0896-6273(91)90052-2. PMID:1673054.
121. Selkoe, D.J. 2001. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81(2): 741-766. PMID:11274343.
122. Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., et al. 1992. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature, 359(6393): 325-327. doi:10.1038/359325a0. PMID:1406936.
123. Shepardson, N.E., Shankar, G.M., and Selkoe, D.J. 2011. Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies. Arch. Neurol. 68(10): 1239-1244. doi:10.1001/archneurol.2011.203. PMID:21987540.
124. Shobab, L.A., Hsiung, G.Y., and Feldman, H.H. 2005. Cholesterol in Alzheimer's disease. Lancet Neurol. 4(12): 841-852. doi:10.1016/ S1474-4422(05)70248-9. PMID:16297842.
125. Simons, M., Keller, P., De Strooper, B., Beyreuther, K., Dotti, C.G., and Simons, K. 1998. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. U. S.A. 95(11): 6460-6464. doi:10.1073/pnas.95.11.6460. PMID: 9600988.
126. Sparks, D.L. 1997. Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease? Ann. N. Y. Acad. Sci. 826(1 Cerebrovascul): 128-146. doi:10.1111/j.1749-6632.1997. tb48466.x. PMID:9329686.
127. Sprong, H., van der Sluijs, P., and van Meer, G. 2001. How proteins move lipids and lipids move proteins. Nat. Rev. Mol. Cell Biol. 2 (7): 504-513. PMID:11433364.
128. Stefani, M., and Liguri, G. 2009. Cholesterol in Alzheimer's disease: unresolved questions. Curr. Alzheimer Res. 6(1): 15-29. doi:10. 2174/156720509787313899. PMID:19199871.
129. Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S., and Roses, A.D. 1993. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90(5): 1977-1981. doi:10.1073/pnas.90.5.1977. PMID:8446617.
130. Suzuki, K., Parker, C.C., Pentchev, P.G., Katz, D., Ghetti, B., D'Agostino, A.N., and Carstea, E.D. 1995. Neurofibrillary tangles in Niemann-Pick disease type C. Acta Neuropathol. 89(3): 227-238. doi:10.1007/BF00309338. PMID:7754743.
131. Takahashi, R.H., Milner, T.A., Li, F., Nam, E.E., Edgar, M.A., Yamaguchi, H., et al. 2002. Intraneuronal Alzheimer Ab42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am. J. Pathol. 161(5): 1869-1879. doi:10. 1016/S0002-9440(10)64463-X. PMID:12414533.
132. Takahashi, R.H., Almeida, C.G., Kearney, P.F., Yu, F., Lin, M.T., Milner, T.A., and Gouras, G.K. 2004. Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain. J. Neurosci. 24(14): 3592-3599. doi:10.1523/JNEUROSCI.5167-03.2004. PMID:15071107.
133. Tampellini, D., Magrane, J., Takahashi, R.H., Li, F., Lin, M.T., Almeida, C.G., and Gouras, G.K. 2007. Internalized antibodies to the Ab domain of APP reduce neuronal Ab and protect against synaptic alterations. J. Biol. Chem. 282(26): 18895-18906. doi:10. 1074/jbc.M700373200. PMID:17468102.
134. Thiele, C., Hannah, M.J., Fahrenholz, F., and Huttner, W.B.2000. Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles. Nat. Cell Biol.2(1): 42-49. PMID:10620806.
135. Vance, J.E. 2006. Lipid imbalance in the neurological disorder, Niemann-Pick C disease. FEBS Lett. 580(23): 5518-5524. PMID: 16797010.
136. Vetrivel, K.S., and Thinakaran, G. 2010. Membrane rafts in Alzheimer's disease beta-amyloid production. Biochim. Biophys. Acta, 1801(8): 860-867. PMID:20303415.
137. Wada, S., Morishima-Kawashima, M., Qi, Y., Misono, H., Shimada, Y., Ohno-Iwashita, Y., and Ihara, Y. 2003. Gamma-secretase activity is present in rafts but is not cholesterol-dependent. Biochemistry, 42(47): 13977-13986. doi:10.1021/bi034904j. PMID:14636066.
138. Wahrle, S., Das, P., Nyborg, A.C., McLendon, C., Shoji, M., Kawarabayashi, T., et al. 2002. Cholesterol-dependent gammasecretase activity in buoyant cholesterol-rich membrane microdomains. Neurobiol. Dis. 9(1): 11-23. doi:10.1006/nbdi.2001. 0470. PMID:11848681.
139. Wakabayashi, M., and Matsuzaki, K. 2007. Formation of amyloids by Ab-(1-42) on NGF-differentiated PC12 cells: roles of gangliosides and cholesterol. J. Mol. Biol. 371(4): 924-933. doi:10.1016/j.jmb. 2007.06.008. PMID:17597153.
140. Wakabayashi, M., Okada, T., Kozutsumi, Y., and Matsuzaki, K. 2005. GM1 ganglioside-mediated accumulation of amyloid beta-protein on cell membranes. Biochem. Biophys. Res. Commun. 328(4): 1019-1023. doi:10.1016/j.bbrc.2005.01.060. PMID:15707979.
141. Waterham, H.R. 2006. Defects of cholesterol biosynthesis. FEBS Lett. 580(23): 5442-5449. doi:10.1016/j.febslet.2006.07.027. PMID:16876788.
142. Wirths, O., and Bayer, T.A. 2010. Neuron loss in transgenic mouse models of Alzheimer's disease. Int. J. Alzheimers Dis. 2010: 2010. PMID:20871861.
143. Wirths, O., Multhaup, G., and Bayer, T.A. 2004. A modified betaamyloid hypothesis: intraneuronal accumulation of the betaamyloid peptide-the first step of a fatal cascade. J. Neurochem. 91(3): 513-520. doi:10.1111/j.1471-4159.2004.02737.x. PMID: 15485483.
144. Wood, W.G., Schroeder, F., Igbavboa, U., Avdulov, N.A., and Chochina, S.V. 2002. Brain membrane cholesterol domains, aging and amyloid beta-peptides. Neurobiol. Aging, 23(5): 685-694. doi:10.1016/S0197-4580(02)00018-0. PMID:12392774.
145. Xiong, H., Callaghan, D., Jones, A., Walker, D.G., Lue, L.F., Beach, T.G., et al. 2008. Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Ab production. Neurobiol. Dis. 29(3): 422-437. doi:10.1016/j.nbd. 2007.10.005. PMID:18086530.
146. Yamazaki, T., Chang, T.Y., Haass, C., and Ihara, Y. 2001. Accumulation and aggregation of amyloid beta-protein in late endosomes of Niemann-pick type C cells. J. Biol. Chem. 276(6): 4454-4460. doi:10.1074/jbc.M009598200. PMID:11085995.
147. Yanagisawa, K. 2011. Pathological significance of ganglioside clusters in Alzheimer's disease. J. Neurochem. 116(5): 806-812. doi:10.1111/j.1471-4159.2010.07006.x. PMID:21214549.
148. Yang, A.J., Knauer, M., Burdick, D.A., and Glabe, C. 1995. Intracellular A beta 1-42 aggregates stimulate the accumulation of stable, insoluble amyloidogenic fragments of the amyloid precursor protein in transfected cells. J. Biol. Chem. 270(24): 14786-14792. doi:10.1074/jbc.270.24.14786. PMID:7782344.
149. Yang, A.J., Chandswangbhuvana, D., Shu, T., Henschen, A., and Glabe, C.G. 1999. Intracellular accumulation of insoluble, newly synthesized abetan-42 in amyloid precursor protein-transfected cells that have been treated with Ab1-42. J. Biol. Chem. 274(29): 20650-20656. doi:10.1074/jbc.274.29.20650. PMID:10400697.
150. Yao, Z.X., and Papadopoulos, V. 2002. Function of beta-amyloid in cholesterol transport: a lead to neurotoxicity. FASEB J. 16(12): 1677-1679. PMID:12206998.
151. Yasojima, K., McGeer, E.G., and McGeer, P.L. 2001. 3-hydroxy-3- methylglutaryl-coenzyme A reductase mRNA in Alzheimer and control brain. Neuroreport, 12(13): 2935-2938. PMID:11588606.
152. Yip, C.M., Elton, E.A., Darabie, A.A., Morrison, M.R., and McLaurin, J. 2001. Cholesterol, a modulator of membraneassociated Ab-fibrillogenesis and neurotoxicity. J. Mol. Biol. 311 (4): 723-734. doi:10.1006/jmbi.2001.4881. PMID:11518526.
153. Zerbinatti, C.V., Wahrle, S.E., Kim, H., Cam, J.A., Bales, K., Paul, S.M., et al. 2006. Apolipoprotein E and low density lipoprotein receptor-related protein facilitate intraneuronal Ab42 accumulation in amyloid model mice. J. Biol. Chem. 281(47): 36180-36186. doi:10.1074/jbc.M604436200. PMID:17012232.
154. Zhang, Y., McLaughlin, R., Goodyer, C., and LeBlanc, A. 2002. Selective cytotoxicity of intracellular amyloid beta peptide 1-42 through p53 and Bax in cultured primary human neurons. J. Cell Biol. 156(3): 519-529. doi:10.1083/jcb.200110119. PMID: 11815632.